The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just read the RNS released yesterday, never a fan of none financial earn out targets, and even less of a fan of deferred consideration being paid out in cash! Take a look at The Panoply to see how it should be done... Very disappointing newsflow & performance since IPO.
"Since acquisition, Horizon's platform MicroGuide has grown revenue and delivered +32.0% YoY growth in registered users and +44% YoY growth in guideline page views as at 27 August 2020.
As part of the purchase agreement and as a result of Horizon achieving its earn-out target, a deferred contingent consideration of £1.5 million will be paid in cash."
Somebody loaded up big time after the bell yesterday.... 114k Worth....
Yeah agree I am tempted to buy some and prob will
Do . This has to be the future right and NHS needs to modernise . Shame I don’t know any healthcare workers who use the apps but reviews are very good . Feels like a high risk share though . Can they make money? It is not that clear to me . Reckon it’s a punt long term hold
I think it's very much under the radar but given it's already in key Hospitals and only listed for a year shows me the potential is very much ahead. Founders with solid track record and some key investors such as Dermot Desmond tells me well worth having a look at it. Potential is very good and with all the recent Covid impact then fully expect solid growth.This has long been overdue for the Health centre.
https://www.proactiveinvestors.co.uk/companies/news/920159/induction-healthcare-to-acquire-zesty-limited-as-it-builds-out-platform-for-medical-professionals-920159.html
Watching the video I found useful . Adding premium features to app . Charging hospitals I think
Well it certainly has the right investors on the board and with Covid disrupting the norm this share is well worth investing in. Proven track record from the key people in past ventures.
I am looking at this share as a possible investment BUT what I do not understand is what drives the revenue? Is the App itself licenced on payable basis? Or does the hospital buy the overall capability and pay for unlimited user licences?
I am trying to understand how the revenue will scale upwards over time with more users/hospitals using
Induction Healthcare snaps up healthtech platform Zesty - https://bit.ly/36cjWYc
why has the message (this pm) gone from prof news ? why is my purchase of 2k this pm showing as a sell?
So reading through the last accounts it seems there is zero revenue and they did not talk about where any revenue could come from - I will dig further but I am not sure what the future holds for this one at the moment
This post could stay unread for some time. I say this because I attended Thursday’s AGM and I was the only retail investor there. It did make QA at the end interesting though. This is an unusual investment for me because I don’t do IPO’s and in fact only bought the stock recently. The reason was an old friend who lives in Australia had invested and encouraged me to do the same.
My pal’s reasons were basically the pedigree of those involved and personal contacts. I attended the AGM for both of our interests. This post is not about the potential of the company because you can read the AIM admission document and learn as much as me. What I did find intriguing though was the list of stockholders. There are few retail investors and the IPO wasn’t about raising finance from the public. I know this because I asked.
You can see yourself that the free float is arguably only about 8% and as those holding under 3% do not have to report their holding it really could mean that me and my pal may be the only retail investors (I’m joking but all trades since IPO are shown and there aren’t that many). Ignoring the concert party the major holders are Dermot Desmond and Woodford Investment (c.30%) who are not day traders so this bulletin board will be free of them. The shares are held tightly so shorting will be next to impossible and those involved are professional and know these things take time. If you’re impatient I wouldn’t bother investing here.
It was explained to me that the reason for the AIM quote is because they are on the acquisition trail and it makes it easier to purchase companies if they are publicly quoted. This was a lesson learned from the successful buy and build strategies followed at DrugDev and Quintiles. The people involved in INHC know how to make this succeed.
If anyone finds this message either tick the recommend box or say hello.
Build it and they will come.